Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848419575Aexternal-prioritypatent/GB8419575D0/en
Priority claimed from GB08519418Aexternal-prioritypatent/GB2162522B/en
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Publication of MY102564ApublicationCriticalpatent/MY102564A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A COMPOUND OF FORMULA (1)@@@(FORMULA 1)@@@AN ITS PHYSIOLOGICALLY ACCEPTABLE SALTS AND SOLVATES ARE DESCRIBED AS USEFUL IN TREATING AND/OR PREVENTING PAIN RESULTING FROM DILATATION OF THE CRANIAL OF THE CRANIAL VASCULATURE IN PARTICULAR MIGRAINE. THE COMPOUND (I) MAY BE PREPARED, FOR EXAMPLE BY CYCLISING A COMPOUND OF FORMULA (II)@@@(FORMULA 2)
Tricyclic compounds and method of inhibiting the tyrasin kinases receptors of the epidermal growth factor, pharmaceutical composition, methods of preventing the blastocites implantation and mammals treatment